Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608465 · ClinicalTrials.gov registry record · Phase 4
Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
A Phase 4 study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT00608465: Clinical Trial Phase 4 study, sponsored by Vanderbilt University.
NCT00608465 is a Phase 4 study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 4 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00608465, a Phase 4 study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
The combination of high blood pressure and having central obesity is an increasing important factor for heart disease in men and women. It can also lead to the early development of hardening of the arteries and increased risk of a stroke. This study will analyze patients' genetic make up to identify who may be at greater risk for heart disease and strokes in relationship to high blood pressure and central obesity.
Interventions
- DRUG Ramipril
- DRUG Eplerenone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-05 |
| Est. Completion | 2011-05 |
| Phase | Phase 4 |
Why NCT00608465 stopped before completion
NCT00608465 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Ramipril is the first listed.
NCT00608465 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00608465 about?
NCT00608465 is a clinical study titled "Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity". The combination of high blood pressure and having central obesity is an increasing important factor for heart disease in men and women. It can also lead to the early development of hardening of the arteries and increased risk of a stroke. This study will analyze patients' genetic make up to identify...
What is the current status of trial NCT00608465?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2006-05. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00608465?
The interventions under investigation include: Ramipril (DRUG), Eplerenone (DRUG).
Who is sponsoring clinical trial NCT00608465?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00608465's enrollment target sits among peer trials
4 1994th of 2000 higher than 6 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia